ORG-201745

Chemical compound
  • 1225638-79-8

ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]

References

  1. ^ "ORG 201745 - AdisInsight". adisinsight.springer.com.
  • v
  • t
  • e
Progesterone receptor modulators
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
See also
Receptor/signaling modulators
Progestogens and antiprogestogens
Androgen receptor modulators
Estrogen receptor modulators
List of progestogens


Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e